Belgium has decided to temporarily ban the use of Novo Nordisk’s diabetes drug Ozempic as a weight loss treatment amid a shortage of the medicine, according to a royal decree Read More
Let's stay in touch. Subscribe to our blog and get our best content in your inbox.